MYLK and graft versus host disease: Mice lacking MLCK210, although may develop GVHD in a Major-Histocompatibility Complex (MHC) mismatched transplant setting, are protected from prolonged intestinal barrier loss and severe GVHD, as shown by reduced tissue damage, decreased number of CD8 + T cells in the gut, and better overall survival [111].